05-23-2402 Calcitonin, Human

05-23-2402
価格&在庫状況を照会

概要

Replacement Information

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
05-23-2402-0.5MGCN
在庫状況検索中…
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル .5 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewSynthetic, human calcitonin. A 32 amino acid peptide that is shown to stimulate bone formation and inhibit bone resorption.
      Catalogue Number05-23-2402
      Brand Family Calbiochem®
      References
      ReferencesGennari, C. and Agnusdei, D. 1994. Br. J. Clin. Pract. 48, 196.
      MacIntyre, I. et al. 1988. Clin. Orthop. 217, 45.
      Chambers, T.J., et al. 1985. J. Pathol. 145, 297.
      Product Information
      CAS number21215-62-3
      FormLyophilized
      FormulationSold on the basis of peptide content.
      Hill FormulaC₁₅₁H₂₂₆N₄₀O₄₅S₃
      Chemical formulaC₁₅₁H₂₂₆N₄₀O₄₅S₃
      Hygroscopic Hygroscopic
      Sold on the basis of peptide contentY
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥96% by HPLC
      Physicochemical Information
      Peptide ContentY
      Peptide SequenceH-Cys¹-Gly-Asn-Leu-Ser-Thr-Cys⁷-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH₂(disulfide bond: 1 → 7)
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSXP3560000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.



      From Catalog:
      Desc. Field- added "A 32 amino acid residue peptide that is shown to stimulate bone formation and inhibit bone resorption.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Calcitonin, Human 試験成績書(CoA)

      タイトルロット番号
      05-23-2402

      参考資料

      参考資料の概要
      Gennari, C. and Agnusdei, D. 1994. Br. J. Clin. Pract. 48, 196.
      MacIntyre, I. et al. 1988. Clin. Orthop. 217, 45.
      Chambers, T.J., et al. 1985. J. Pathol. 145, 297.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-September-2008 RFH
      DescriptionCalcitonin is a single-chain peptide hormone of 32 amino acid residues with a disulfide bridge between cysteines at positions 1 and 7. It is produced in the parafollicular C cells of the thyroid gland and acts to stimulate bone formation by osteoblasts and inhibits bone resorption. Part of the effect of calcitonin appears to be mediated through increasing cAMP concentrations in osteoclasts.
      FormLyophilized
      FormulationSold on the basis of peptide content.
      CAS number21215-62-3
      RTECSXP3560000
      Chemical formulaC₁₅₁H₂₂₆N₄₀O₄₅S₃
      Peptide SequenceH-Cys¹-Gly-Asn-Leu-Ser-Thr-Cys⁷-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH₂(disulfide bond: 1 → 7)
      Purity≥96% by HPLC
      Solubility5% Acetic acid (1 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.



      From Catalog:
      Desc. Field- added "A 32 amino acid residue peptide that is shown to stimulate bone formation and inhibit bone resorption.
      Toxicity Standard Handling
      Merck USA index14, 1643
      ReferencesGennari, C. and Agnusdei, D. 1994. Br. J. Clin. Pract. 48, 196.
      MacIntyre, I. et al. 1988. Clin. Orthop. 217, 45.
      Chambers, T.J., et al. 1985. J. Pathol. 145, 297.